换一批
换一批GLP-1受体激动剂心血管保护机制研究进展
Update on the cardiovascular protective effects of glucagon-like peptide-1 receptor agonists
摘要随着胰高血糖素样肽-1( GLP-1)受体激动剂的广泛应用,越来越多的研究表明,此类药物能够通过调节血糖、血脂、血压,并通过抗炎、抗氧化应激等机制,发挥保护心肌、改善心肌梗死和心力衰竭等方面的效应.
更多相关知识
abstractsAlong with the wide use of glucagon-like peptide-1 ( GLP-1 ) receptor agonists,evidence has been accumulated that GLP-1 receptor agonists could lead to myocardial protection,improvement of myocardial infarction and heart failure by ways of regulating blood glucose,lipid and blood pressure,anti-inflammation and anti-oxidative stress,etc.
More相关知识
关键词
胰高血糖素样肽-1炎症氧化应激心肌梗死心力衰竭Glucagon-like peptide-1InflammationOxidative stressMyocardial infarctionHeart failure
分类号
R714.147
栏目名称
临床研究
DOI
10.3760/cma.j.issn.1673-4157.2012.04.008
发布时间
2012-11-23
- 浏览328
- 被引0
- 下载113
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
